Healthcare’s relationships with AI and digital transformation are a mix of excitement and uncertainty. Even as hospitals begin to see returns on their technology deployments, leaders acknowledge that ...

In 2016, patient non-adherence was estimated to cost U.S. pharmaceutical companies a staggering $250 billion in potential annual sales. Why does this issue still persist nearly a decade later? For ...

Through a new partnership, Teladoc Health's virtual services are now available on Walmart's Better Care Services platform.

Massachusetts Attorney General Andrea Joy Campbell sued UnitedHealthcare on Friday, alleging the insurer “falsely manipulated” the health status of MassHealth members enrolled in the Senior Care ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, ...

Three health systems are suing CVS Health, alleging the company and its pharmacy subsidiaries diverted roughly $250 million in savings from the 340B Drug Pricing Program. The 340B program was ...

Employer advocates said Cost Plus Wellness could help spur more direct contracting and transparency in healthcare, though ...

Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca Health, a pharmacy benefit manager. MedCity News was invited to host and ...

GoodRx, a prescription savings company, launched a new offering on Monday that delivers a cost-plus pricing model for independent pharmacies. Santa Monica, California-based GoodRx helps consumers ...

On Wednesday, 60 organizations representing providers and patients with cancer submitted a letter to Robert F. Kennedy Jr., secretary of Health and Human Services, urging him to protect the U.S.

At Wayne General Hospital in rural Mississippi, clinicians say AI-powered stethoscope usage is helping them detect heart problems earlier in patients who often have limited access to specialists. The ...

Most disputes between pharmaceutical companies and generic drugmakers end in settlements. Five years of class-action litigation over a Takeda Pharmaceutical gastrointestinal drug culminated this week ...